fluorouracil has been researched along with Carcinoma, Basal Cell, Pigmented in 250 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We identified 5700 subjects who filled prescriptions for 5-fluorouracil or imiquimod for treatment of actinic keratosis in 2007." | 7.91 | Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. ( Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z, 2019) |
| "The authors previously reported the safety and short-term efficacy of ablative fractional laser (AFXL)-assisted delivery of topical fluorouracil in the treatment of superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis)." | 7.83 | Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study. ( Gan, SD; Hsu, SH; Konnikov, N; Liang, CA; Nguyen, BT, 2016) |
| "An 85-year-old woman, with known stable angina pectoris, was prescribed 5-fluorouracil cream to treat a small basal cell carcinoma on the forehead." | 7.69 | Myocardial ischemia induced by topical use of 5-fluorouracil. ( Gotsman, MS; Gurewich, J; Rozenman, Y, 1995) |
| "We describe the successful treatment of porokeratosis of Mibelli of the left calf in an 83-year-old man with topical 5 percent imiquimod and topical 5 percent 5-fluorouracil." | 5.36 | Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. ( LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D, 2010) |
| "A 58-year-old man with basal cell nevus syndrome had variously sized basal cell epitheliomas (BCEs), mostly of the superficial type, on his chest, back, and lumbar areas." | 5.29 | Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. ( Nishimura, M; Otake, N; Tsuji, T, 1993) |
| "A single patient with basal cell nevus syndrome is presented." | 5.27 | Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene. ( Hazen, PG; Taub, SJ, 1984) |
| "The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation." | 5.25 | Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers. ( Ichinose, H; Krementz, ET; Litwin, MS; Mansell, PW, 1975) |
| " Keratoacanthomas had high cure rates with intralesional agents: 98% for 5FU, 91% for methotrexate, 100% for bleomycin, 100% for IFN alpha (α)-2, 83% for IFN α-2a, and 100% for IFN α-2b." | 4.89 | Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. ( Chitwood, K; Cohen, G; Etzkorn, J, 2013) |
| "We identified 5700 subjects who filled prescriptions for 5-fluorouracil or imiquimod for treatment of actinic keratosis in 2007." | 3.91 | Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. ( Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z, 2019) |
| "The authors previously reported the safety and short-term efficacy of ablative fractional laser (AFXL)-assisted delivery of topical fluorouracil in the treatment of superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis)." | 3.83 | Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study. ( Gan, SD; Hsu, SH; Konnikov, N; Liang, CA; Nguyen, BT, 2016) |
| "An 85-year-old woman, with known stable angina pectoris, was prescribed 5-fluorouracil cream to treat a small basal cell carcinoma on the forehead." | 3.69 | Myocardial ischemia induced by topical use of 5-fluorouracil. ( Gotsman, MS; Gurewich, J; Rozenman, Y, 1995) |
| "Successful management of keratoacanthomas and basal-cell epitheliomas by intralesional injections of 5-fluorouracil is reported." | 3.66 | Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU). ( Kurtis, B; Rosen, T, 1980) |
| "15 patients with superficial basaliomas or premalignant epithelial neoplastic disorders (actinic keratosis, leukoplakia, Bowen's disease) were treated locally over three weeks with retinoic acid (RA) alone or in combination with 5-fluorouracil (5-FU)." | 3.66 | [Vitamin A acid for the topical management of epithelial neoplasms. Combination with 5-fluorouracil]. ( Kurka, M; Orfanos, CE; Pullmann, H, 1978) |
| "Treatment with fluorouracil, trichloroacetic acid, or carbon dioxide laser resulted in an 83% to 92% reduction in AKs (P< or =." | 2.72 | Facial resurfacing for nonmelanoma skin cancer prophylaxis. ( Cooper, ZA; Hantash, BM; Koch, RJ; Rehmus, WE; Stewart, DB; Swetter, SM, 2006) |
| "Skin cancer is a broad term used to describe a number of different malignant indications of the skin." | 2.66 | Topical treatments for skin cancer. ( Boyle, GM; Cullen, JK; Parsons, PG; Simmons, JL, 2020) |
| "Chemoprevention of nonmelanoma skin cancer should be considered in patients likely to develop numerous, invasive, or metastatic nonmelanoma skin cancers." | 2.61 | Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer. ( Council, ML; Nemer, KM, 2019) |
| "Nonmelanoma skin cancer (NMSC) is the most common cancer in patients and includes basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)." | 2.53 | Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies. ( Cherpelis, B; Rudnick, EW; Thareja, S, 2016) |
| "Nonmelanoma skin cancer, which encompasses basal cell and squamous cell carcinoma, is the most common cancer in the United States." | 2.48 | Diagnosis and treatment of Basal cell and squamous cell carcinoma. ( Firnhaber, JM, 2012) |
| "With regard to squamous cell carcinoma, treatment with 5-fluorouracil, methotrexate, interferon, and bleomycin are reviewed." | 2.47 | Intralesional agents in the management of cutaneous malignancy: a review. ( Good, LM; High, WA; Miller, MD, 2011) |
| "An updated review of management of nevoid basal cell carcinoma syndrome (NBCCS) is presented." | 2.44 | Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments. ( Mitropoulos, P; Norman, R, 2008) |
| "The ability to manage non-melanoma skin cancers and pre-malignant lesions with topical pharmacologic agents is highly compelling." | 2.42 | Topical treatment strategies for non-melanoma skin cancer and precursor lesions. ( Fein, H; McGillis, ST, 2004) |
| "An integrated program of skin cancer awareness, sun protection, and prophylactic approaches is critical." | 2.41 | Nonmelanoma skin cancer. ( Ho, DQ; Nguyen, TH, 2002) |
| "Non-melanoma skin cancer (NMSC), which includes both Bowen's disease (BD) and superficial basal cell carcinoma (sBCC), is the most commonly diagnosed cancer in Canada." | 1.91 | Cryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma. ( Nazarali, S; Sajic, D, 2023) |
| "AFL-assisted cisplatin + 5-FU in double sessions represents an acceptable and safe treatment strategy for low-risk sBCC, while clearance rates following single treatment or for nBCC seem inferior." | 1.72 | Efficacy and safety of laser-assisted combination chemotherapy: A follow-up study of treatment with 5-fluorouracil and cisplatin for basal cell carcinoma. ( Fredman, G; Haedersdal, M; Hendel, K; Togsverd-Bo, K; Wenande, E, 2022) |
| "Non-melanoma skin cancer (NMSC) is the most common malignancy worldwide, with rising incidence in the recent years." | 1.72 | In vitro 5-Fluorouracil resistance produces enhanced photodynamic therapy damage in SCC and tumor resistance in BCC. ( Gilaberte, Y; González, S; Gutiérrez-Pérez, M; Juarranz, Á; Nicolás-Morala, J; Portillo-Esnaola, M; Terrén, S, 2022) |
| " It provides a promising long-term relief with a tolerable side-effect profile." | 1.72 | Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas. ( Gupta, P; Kaur, M; Mehta Grewal, A; Sharma, M; Singh, H; Singh, M; Zadeng, Z, 2022) |
| "Mitomycin C was more effective in inducing the apoptosis of basal cell carcinoma than 5-fluorouracil and their combination." | 1.62 | Optimizing the effective doses of mitomycin C, 5-fluorouracil, and their combination on cultivated basal cell carcinoma. ( Aletaha, M; Balagholi, S; Dabbaghi, R; Kanavi, MR; Karami, S; Nakhaie, PA, 2021) |
| "When treating invasive basal cell carcinoma (BCC) with Mohs micrographic surgery (MMS), including infiltrative and nodular subtypes, the goal is complete surgical removal of the tumor." | 1.56 | Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery. ( Housewright, C; Pederson, H; Staples, CJ, 2020) |
| "5-fluorouracil (5-FU) is a cytostatic drug associated with antimetabolite effects and already approved as monotherapy for superficial BCCs treatment." | 1.51 | Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution. ( Bianchi, L; Campione, E; Diluvio, L; Lanna, C; Lozzi, F; Palumbo, V, 2019) |
| "Superficial basal cell carcinoma is a type of keratinocyte carcinoma that has increasing incidence and substantial morbidity." | 1.48 | Comparing Topical Treatments for Basal Cell Carcinoma. ( Shaw, FM; Weinstock, MA, 2018) |
| "Toxicity was acceptable, with grade 3 renal failure (n=1) and grade 3 or 4 myelotoxicity (n=2)." | 1.43 | Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer. ( Dietrich, PY; Espeli, V; Hottinger, AF; Modarressi, A; Ruegg, E, 2016) |
| "The incidence of non-melanoma skin cancer (NMSC), including actinic keratosis (AK), squamous cell carcinoma (SCC), Bowen's Disease (BD) and basal cell carcinoma (BCC), is increasing." | 1.42 | Field cancerization: from molecular basis to selective field-directed management of actinic keratosis. ( Philipp-Dormston, WG, 2015) |
| "These activities compared with those in squamous cell carcinoma." | 1.36 | [Four resected cases with basaloid carcinoma of esophagus--comparison of 5-FU-related enzymes (thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT)) between basaloid carcinoma and squamous cell carcin ( Fujiwara, Y; Morimura, K; Takemura, M; Yoshida, K, 2010) |
| "We describe the successful treatment of porokeratosis of Mibelli of the left calf in an 83-year-old man with topical 5 percent imiquimod and topical 5 percent 5-fluorouracil." | 1.36 | Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. ( LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D, 2010) |
| "Non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma, also represent sun-related conditions that require early and aggressive treatment." | 1.36 | Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments. ( Goldsmith, A; Han, A; Marmur, ES; Penrose, C, 2010) |
| "Twenty-five squamous cell carcinomas, 1 melanoma, 2 basocellular carcinomas and 2 adenoid cystic carcinomas were treated." | 1.33 | [The outcome of treatments for carcinoma of the external auditory canal]. ( Delalande, C; Dumas, G; Lavieille, JP; Reyt, E; Righini, Ch; Schmerber, S; Soriano, E, 2005) |
| "A 58-year-old man with basal cell nevus syndrome had variously sized basal cell epitheliomas (BCEs), mostly of the superficial type, on his chest, back, and lumbar areas." | 1.29 | Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. ( Nishimura, M; Otake, N; Tsuji, T, 1993) |
| "A single patient with basal cell nevus syndrome is presented." | 1.27 | Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene. ( Hazen, PG; Taub, SJ, 1984) |
| "To improve the results, we have treated the squamous cell carcinomas with topical 5-fluorouracil to obtain sensitization and shrinkage of the tumor before resection." | 1.27 | Topical 5-fluorouracil in treatment of carcinoma of nasal floor and nasal alae. ( Marks, MW; Ryan, RF, 1988) |
| "The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation." | 1.25 | Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers. ( Ichinose, H; Krementz, ET; Litwin, MS; Mansell, PW, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 138 (55.20) | 18.7374 |
| 1990's | 10 (4.00) | 18.2507 |
| 2000's | 20 (8.00) | 29.6817 |
| 2010's | 64 (25.60) | 24.3611 |
| 2020's | 18 (7.20) | 2.80 |
| Authors | Studies |
|---|---|
| Neale, H | 1 |
| Michelon, M | 1 |
| Jacob, S | 1 |
| Pinkston, M | 1 |
| Ukaegbu, R | 1 |
| Zamor, W | 1 |
| Morrison, E | 1 |
| Deng, A | 1 |
| Levin, NA | 1 |
| Fredman, G | 1 |
| Wenande, E | 2 |
| Hendel, K | 2 |
| Togsverd-Bo, K | 2 |
| Haedersdal, M | 2 |
| Nicolás-Morala, J | 1 |
| Portillo-Esnaola, M | 1 |
| Terrén, S | 1 |
| Gutiérrez-Pérez, M | 1 |
| Gilaberte, Y | 1 |
| González, S | 1 |
| Juarranz, Á | 1 |
| Gil-Lianes, J | 1 |
| Morgado-Carrasco, D | 1 |
| Algarin, YA | 1 |
| Jambusaria-Pahlajani, A | 2 |
| Ruiz, E | 1 |
| Patel, VA | 2 |
| Yu, Y | 1 |
| Zhang, G | 1 |
| Fu, S | 1 |
| Krieter, M | 1 |
| Schultz, E | 1 |
| Nazarali, S | 1 |
| Sajic, D | 1 |
| Collins, A | 1 |
| Savas, J | 1 |
| Doerfler, L | 1 |
| Cullen, JK | 1 |
| Simmons, JL | 1 |
| Parsons, PG | 1 |
| Boyle, GM | 1 |
| Cornejo, CM | 1 |
| Willenbrink, TJ | 1 |
| Schmults, CD | 1 |
| Arron, ST | 2 |
| Ruiz, ES | 2 |
| Pederson, H | 1 |
| Staples, CJ | 1 |
| Housewright, C | 1 |
| Gilchrest, BA | 1 |
| Mogensen, M | 1 |
| Bagger, C | 1 |
| Mårtensson, NL | 1 |
| Persson, DP | 1 |
| Lerche, CM | 1 |
| Husted, S | 1 |
| Janfelt, C | 1 |
| Anderson, RR | 1 |
| Maghfour, J | 1 |
| Kuraitis, D | 1 |
| Murina, A | 1 |
| Balagholi, S | 1 |
| Aletaha, M | 1 |
| Kanavi, MR | 1 |
| Karami, S | 1 |
| Dabbaghi, R | 1 |
| Nakhaie, PA | 1 |
| Nahm, WJ | 1 |
| Shen, J | 1 |
| Zito, PM | 1 |
| Gonzalez, AM | 1 |
| Nagrani, N | 1 |
| Moore, K | 1 |
| Badiavas, EV | 1 |
| Kirsner, RS | 1 |
| Nichols, AJ | 1 |
| Means, AD | 3 |
| Leader, NF | 3 |
| Siegel, JA | 3 |
| Walker, JL | 1 |
| Pomerantz, H | 1 |
| Beatson, M | 3 |
| Weinstock, MA | 7 |
| Singh, M | 1 |
| Mehta Grewal, A | 1 |
| Singh, H | 1 |
| Sharma, M | 1 |
| Kaur, M | 1 |
| Gupta, P | 1 |
| Zadeng, Z | 1 |
| Ariza, S | 1 |
| Espinosa, S | 1 |
| Naranjo, M | 1 |
| Klinghammer, K | 1 |
| Otto, R | 1 |
| Raguse, JD | 1 |
| Albers, AE | 1 |
| Tinhofer, I | 1 |
| Fichtner, I | 1 |
| Leser, U | 1 |
| Keilholz, U | 1 |
| Hoffmann, J | 1 |
| Essers, BAB | 3 |
| Arits, AH | 5 |
| Hendriks, MR | 1 |
| Mosterd, K | 9 |
| Kelleners-Smeets, NW | 6 |
| Jansen, MHE | 3 |
| Arits, AHMM | 4 |
| Roozeboom, MH | 5 |
| Sommer, A | 3 |
| van Pelt, HPA | 1 |
| Quaedvlieg, PJF | 2 |
| Steijlen, PM | 3 |
| Nelemans, PJ | 7 |
| Kelleners-Smeets, NWJ | 4 |
| Thwin, SS | 1 |
| Marcolivio, K | 1 |
| Shaw, FM | 2 |
| Hogan, D | 1 |
| Eilers, D | 1 |
| Swetter, SM | 2 |
| Chen, SC | 1 |
| Jacob, SE | 1 |
| Warshaw, EM | 1 |
| Stricklin, GP | 1 |
| Dellavalle, RP | 1 |
| Sidhu-Malik, N | 1 |
| Konnikov, N | 3 |
| Werth, VP | 1 |
| Keri, JE | 1 |
| Robinson-Bostom, L | 2 |
| Ringer, RJ | 1 |
| Lew, RA | 1 |
| Ferguson, R | 1 |
| DiGiovanna, JJ | 2 |
| Huang, GD | 1 |
| Yoon, J | 1 |
| Phibbs, CS | 1 |
| Chow, A | 1 |
| Koekelkoren, FHJ | 1 |
| Neal, DE | 1 |
| Smith, RJ | 1 |
| Aberbigbe, O | 1 |
| Etzkorn, JR | 1 |
| Milosevic, M | 1 |
| Lazarevic, M | 1 |
| Toljic, B | 1 |
| Simonovic, J | 1 |
| Trisic, D | 1 |
| Nikolic, N | 1 |
| Petrovic, M | 1 |
| Milasin, J | 1 |
| Neugebauer, R | 1 |
| Su, KA | 1 |
| Zhu, Z | 1 |
| Sokil, M | 1 |
| Chren, MM | 2 |
| Friedman, GD | 1 |
| Asgari, MM | 1 |
| Basset-Seguin, N | 1 |
| van Delft, LCJ | 1 |
| Hamid, MA | 1 |
| Rosenberg, AR | 1 |
| Tabacchi, M | 1 |
| Ngo, KH | 1 |
| Wallendorf, M | 1 |
| Rosman, IS | 1 |
| Cornelius, LA | 1 |
| Demehri, S | 1 |
| Diluvio, L | 1 |
| Lanna, C | 1 |
| Lozzi, F | 1 |
| Palumbo, V | 1 |
| Bianchi, L | 1 |
| Campione, E | 1 |
| Nemer, KM | 1 |
| Council, ML | 1 |
| Lyons, AB | 1 |
| Mitchell, DA | 1 |
| Moy, RL | 1 |
| Dummer, R | 2 |
| Essers, BA | 2 |
| Spoorenberg, E | 2 |
| De Rooij, MJ | 1 |
| van Pelt, HP | 1 |
| Quaedvlieg, PJ | 1 |
| Krekels, GA | 1 |
| van Neer, PA | 1 |
| Rijzewijk, JJ | 1 |
| van Geest, AJ | 1 |
| Apalla, Z | 1 |
| Lallas, A | 1 |
| Sotiriou, E | 1 |
| Ioannides, D | 1 |
| Arits, A | 2 |
| Chitwood, K | 1 |
| Etzkorn, J | 1 |
| Cohen, G | 1 |
| Xiong, MY | 1 |
| Korgavkar, K | 1 |
| Schulze Schwering, M | 1 |
| Schwering, MS | 1 |
| Chagaluka, G | 1 |
| Molyneux, E | 1 |
| Nelemans, P | 2 |
| Konda, S | 1 |
| O'Bryan, KW | 1 |
| Ratner, D | 1 |
| Goddard, L | 1 |
| Mollet, T | 1 |
| Blalock, T | 1 |
| Gibbs, S | 1 |
| Davis, T | 1 |
| Wang, H | 1 |
| Xu, Y | 1 |
| Shi, J | 1 |
| Gao, X | 1 |
| Geng, L | 1 |
| Philipp-Dormston, WG | 1 |
| Lecluse, LL | 1 |
| Spuls, PI | 1 |
| Kelleners-Smeets, N | 1 |
| Nijsten, T | 1 |
| Klein, E | 13 |
| Stoll, HL | 5 |
| Milgrom, H | 5 |
| Traenkle, HL | 3 |
| Graham, S | 2 |
| Helm, F | 5 |
| Poulalhon, N | 1 |
| Dalle, S | 1 |
| Balme, B | 1 |
| Thomas, L | 1 |
| Nguyen, BT | 2 |
| Gan, SD | 2 |
| Liang, CA | 2 |
| Knackstedt, TJ | 1 |
| Quitadamo, M | 1 |
| Badea, G | 1 |
| Lacatusu, I | 1 |
| Ott, C | 1 |
| Badea, N | 1 |
| Grafu, I | 1 |
| Meghea, A | 1 |
| van Kleef, L | 1 |
| Winnepenninckx, VJ | 1 |
| van Marion, AM | 1 |
| Cohen, JL | 1 |
| Friedman, A | 1 |
| Rudnick, EW | 1 |
| Thareja, S | 1 |
| Cherpelis, B | 1 |
| Wiznia, LE | 1 |
| Federman, DG | 1 |
| de Rooij, MJM | 1 |
| Espeli, V | 1 |
| Ruegg, E | 1 |
| Hottinger, AF | 1 |
| Modarressi, A | 1 |
| Dietrich, PY | 1 |
| Hsu, SH | 1 |
| Naik, MP | 1 |
| Mehta, A | 1 |
| Abrol, S | 1 |
| Kumar, S | 1 |
| Gupta, VS | 1 |
| Moore, AY | 1 |
| Love, WE | 1 |
| Bernhard, JD | 1 |
| Bordeaux, JS | 1 |
| Good, LM | 1 |
| Miller, MD | 1 |
| High, WA | 1 |
| Micali, G | 1 |
| Lacarrubba, F | 1 |
| Dinotta, F | 1 |
| Massimino, D | 1 |
| Nasca, MR | 1 |
| Kirby, JS | 1 |
| Miller, CJ | 1 |
| Han, A | 1 |
| Penrose, C | 1 |
| Goldsmith, A | 1 |
| Marmur, ES | 1 |
| Has, C | 1 |
| Burger, B | 1 |
| Volz, A | 1 |
| Kohlhase, J | 1 |
| Bruckner-Tuderman, L | 1 |
| Itin, P | 1 |
| Aguayo-Leiva, IR | 1 |
| Ríos-Buceta, L | 1 |
| Jaén-Olasolo, P | 1 |
| Takemura, M | 1 |
| Morimura, K | 1 |
| Yoshida, K | 1 |
| Fujiwara, Y | 1 |
| Vollebergh, MA | 1 |
| Lips, EH | 1 |
| Nederlof, PM | 1 |
| Wessels, LFA | 1 |
| Schmidt, MK | 1 |
| van Beers, EH | 1 |
| Cornelissen, S | 1 |
| Holtkamp, M | 1 |
| Froklage, FE | 1 |
| de Vries, EGE | 1 |
| Schrama, JG | 1 |
| Wesseling, J | 1 |
| van de Vijver, MJ | 1 |
| van Tinteren, H | 1 |
| de Bruin, M | 1 |
| Hauptmann, M | 1 |
| Rodenhuis, S | 1 |
| Linn, SC | 1 |
| Venkatarajan, S | 1 |
| LeLeux, TM | 1 |
| Yang, D | 1 |
| Rosen, T | 4 |
| Orengo, I | 1 |
| Brightman, L | 1 |
| Warycha, M | 1 |
| Anolik, R | 1 |
| Geronemus, R | 1 |
| Tang, JY | 1 |
| Marghoob, AA | 1 |
| Sullivan, TJ | 1 |
| Firnhaber, JM | 1 |
| Čeović, R | 1 |
| Smolković, N | 1 |
| Pašić, A | 1 |
| Kostović, K | 1 |
| Hrsan, D | 1 |
| Endrizzi, B | 1 |
| Ahmed, RL | 1 |
| Ray, T | 1 |
| Dudek, A | 1 |
| Lee, P | 2 |
| Zimmermann, A | 1 |
| Walt, H | 1 |
| Haller, U | 1 |
| Baas, P | 1 |
| Klein, SD | 1 |
| Clayton, AS | 1 |
| Stasko, T | 1 |
| JOHNSON, RO | 1 |
| LANGE, RD | 1 |
| KISKEN, WA | 1 |
| CURRERI, AR | 1 |
| CASE, RW | 2 |
| LAOR, Y | 2 |
| Schmook, T | 1 |
| Stockfleth, E | 1 |
| Beyeler, M | 1 |
| Morcinek, J | 1 |
| Burg, G | 1 |
| McGillis, ST | 1 |
| Fein, H | 1 |
| Chetty, R | 1 |
| Serra, S | 1 |
| Hsieh, E | 1 |
| Schmerber, S | 1 |
| Righini, Ch | 1 |
| Soriano, E | 1 |
| Delalande, C | 1 |
| Dumas, G | 1 |
| Reyt, E | 1 |
| Lavieille, JP | 1 |
| Snipes, CJ | 1 |
| Sniezek, PJ | 1 |
| Walling, HW | 1 |
| Copcu, E | 1 |
| Sivrioglu, N | 1 |
| Baytekin, C | 1 |
| Er, S | 1 |
| Koc, B | 1 |
| Hantash, BM | 1 |
| Stewart, DB | 1 |
| Cooper, ZA | 1 |
| Rehmus, WE | 1 |
| Koch, RJ | 1 |
| Resnik, KS | 1 |
| DiLeonardo, M | 1 |
| Gibbons, G | 1 |
| Prager, R | 1 |
| Khachemoune, A | 1 |
| Gross, K | 1 |
| Kircik, L | 1 |
| Kricorian, G | 1 |
| Koh, DM | 1 |
| Dzik-Jurasz, A | 1 |
| O'Neill, B | 1 |
| Tait, D | 1 |
| Husband, JE | 1 |
| Brown, G | 1 |
| Mitropoulos, P | 1 |
| Norman, R | 1 |
| Chiaffitelli, C | 1 |
| Suarez Halty, L | 1 |
| Cieplinski, W | 1 |
| Carter, DM | 2 |
| Balin, AK | 1 |
| Rogers, M | 1 |
| Bean, DJ | 1 |
| Rees, RS | 1 |
| O'Leary, JP | 1 |
| Lynch, JB | 1 |
| Swanson, NA | 1 |
| Cesteleyn, L | 1 |
| Akuamoa-Boateng, E | 1 |
| Dillaha, CJ | 1 |
| Jansen, GT | 1 |
| Honeycutt, WM | 1 |
| Bradford, AC | 1 |
| Seniukov, MV | 1 |
| Goldobenko, GV | 1 |
| Mardynskiĭ, IuS | 1 |
| Lushnikov, EF | 1 |
| Skoropad, IuD | 1 |
| Hazen, PG | 1 |
| Taub, SJ | 1 |
| Albright, SD | 1 |
| Glickman, FS | 1 |
| Shelley, WB | 1 |
| Wood, MG | 1 |
| Kurtis, B | 2 |
| Yaffee, HS | 1 |
| Grots, I | 1 |
| Monheit, GD | 1 |
| Kovacs, L | 1 |
| Casson, P | 1 |
| Rozenman, Y | 1 |
| Gurewich, J | 1 |
| Gotsman, MS | 1 |
| Goldberg, H | 1 |
| Tsalik, M | 1 |
| Bernstein, Z | 1 |
| Haim, N | 1 |
| Tsuji, T | 1 |
| Otake, N | 1 |
| Nishimura, M | 1 |
| Gupta, AK | 1 |
| Turnbull, DH | 1 |
| Foster, FS | 1 |
| Harasiewicz, KA | 1 |
| Shum, DT | 1 |
| Prussick, R | 1 |
| Watteel, GN | 1 |
| Hurst, LN | 1 |
| Sauder, DN | 1 |
| Miller, BH | 2 |
| Shavin, JS | 1 |
| Cognetta, A | 1 |
| Taylor, RJ | 1 |
| Salasche, S | 1 |
| Korey, A | 1 |
| Orenberg, EK | 2 |
| Johnson, MR | 1 |
| Hageboutros, A | 1 |
| Wang, K | 1 |
| High, L | 1 |
| Smith, JB | 1 |
| Diasio, RB | 1 |
| Telfer, NR | 1 |
| Colver, GB | 1 |
| Bowers, PW | 1 |
| Romagosa, R | 1 |
| Saap, L | 1 |
| Givens, M | 1 |
| Salvarrey, A | 1 |
| He, JL | 1 |
| Hsia, SL | 1 |
| Taylor, JR | 1 |
| Vander Straten, M | 1 |
| Weitzul, S | 1 |
| Cockerell, CJ | 1 |
| Tyring, SK | 1 |
| Nguyen, TH | 1 |
| Ho, DQ | 1 |
| Miki, Y | 1 |
| Kawatsu, T | 1 |
| Matsuda, H | 1 |
| Yamada, T | 1 |
| Kahata, A | 1 |
| Reymann, F | 4 |
| Di Pietro, S | 1 |
| Milani, A | 1 |
| Volterrani, F | 1 |
| Andrews, JM | 1 |
| Stone, SP | 1 |
| Kaplan, LA | 1 |
| Walter, JF | 1 |
| Macknet, KD | 1 |
| Starzycki, Z | 1 |
| Lewis, MB | 1 |
| Labandter, HP | 2 |
| Ryan, RF | 8 |
| Kurka, M | 1 |
| Orfanos, CE | 1 |
| Pullmann, H | 1 |
| Mohs, FE | 1 |
| Jones, DL | 1 |
| Bloom, RF | 1 |
| Gartmann, H | 2 |
| Scialla, SJ | 1 |
| Miskoff, RA | 1 |
| Amon, RB | 1 |
| Goodkin, PE | 1 |
| Auerbach, R | 1 |
| Mansell, PW | 1 |
| Litwin, MS | 8 |
| Ichinose, H | 2 |
| Krementz, ET | 5 |
| Habal, MB | 1 |
| Biano, G | 1 |
| Cavins, JA | 3 |
| Boileau, GA | 1 |
| Murray, JE | 1 |
| Hodge, SJ | 1 |
| Schrodt, GR | 1 |
| Owen, LG | 1 |
| Freeman, RG | 1 |
| Avant, WH | 1 |
| Huff, RC | 1 |
| Golematis, BC | 1 |
| Delikaris, PG | 1 |
| Haritopoulos, NK | 1 |
| Setakis, NG | 1 |
| Greenway, HT | 1 |
| Koperski, JA | 1 |
| Lowe, N | 1 |
| Brown, DM | 1 |
| Inui, M | 1 |
| Korey, AG | 1 |
| Luck, EE | 1 |
| Weppelmann, B | 1 |
| Wheeler, RH | 1 |
| Peters, GE | 1 |
| Stephens, S | 1 |
| Spencer, SA | 1 |
| Meredith, RF | 1 |
| Kim, RY | 1 |
| Salter, MM | 1 |
| Degner, RA | 1 |
| Kerley, SW | 1 |
| McGregor, DH | 1 |
| Dixon, AY | 1 |
| Poljacki, M | 1 |
| Stojanović, S | 1 |
| Svilar, V | 1 |
| Sillman, FH | 1 |
| Sedlis, A | 1 |
| Boyce, JG | 1 |
| Denecke, H | 1 |
| Roloff, R | 1 |
| Marks, MW | 1 |
| Kastl, J | 1 |
| Horácek, J | 1 |
| Epstein, E | 1 |
| Leidi, L | 1 |
| Maina, G | 1 |
| Rappelli, F | 1 |
| Cocola, L | 1 |
| Durando, C | 1 |
| Donegan, WL | 1 |
| Harris, HS | 1 |
| Weidner, F | 1 |
| Stolte, M | 1 |
| Remy, W | 1 |
| Stüttgen, G | 1 |
| Costanza, ME | 1 |
| Dayal, Y | 1 |
| Binder, S | 1 |
| Nathanson, L | 1 |
| Snyderman, RK | 3 |
| Starzynski, TE | 2 |
| Schnellen, B | 1 |
| Ehinger, H | 1 |
| Dogliotti, M | 1 |
| Sams, WM | 1 |
| Dickinson, JT | 1 |
| Rooker, DW | 1 |
| Leonard, JR | 1 |
| Watt, J | 1 |
| Korfsmeier, KH | 1 |
| Gründer, K | 1 |
| Leyh, F | 1 |
| Moskalik, KG | 1 |
| Kozlov, AP | 1 |
| Akimov, AA | 1 |
| Lynch, PJ | 1 |
| Weber, G | 1 |
| Meinert, W | 1 |
| Littlewood, M | 1 |
| Murray, DS | 1 |
| Weinstein, GD | 1 |
| Zala, L | 1 |
| Lasser, A | 1 |
| Johnson, A | 1 |
| Moynahan, EJ | 1 |
| Peck, GL | 1 |
| Reed, RR | 1 |
| Kremetz, ET | 1 |
| Watt, TL | 1 |
| Bragg, FE | 1 |
| Burgess, GH | 2 |
| Bloch, A | 1 |
| Stoll, H | 1 |
| Healy, JB | 1 |
| Ashton, H | 1 |
| Beveridge, GW | 1 |
| Stevenson, CJ | 1 |
| Zackheim, HS | 1 |
| Farber, EM | 1 |
| Reed, RJ | 4 |
| Pollock, WJ | 1 |
| Ebner, H | 3 |
| Gleason, MC | 1 |
| Lopes, CF | 1 |
| Armond, S | 1 |
| Trnka, J | 2 |
| Yamamoto, K | 1 |
| Sasaki, S | 1 |
| Walker, MJ | 1 |
| Ott, F | 2 |
| Storck, H | 1 |
| Avrach, W | 1 |
| Ziprkowski, L | 1 |
| Sykes, MP | 1 |
| Salem, P | 1 |
| Joffe, B | 1 |
| Gueguen, MH | 1 |
| Zeligman, I | 1 |
| Lutzner, MA | 1 |
| Scott, CI | 1 |
| Banzet, P | 1 |
| De la Caffinière, JY | 1 |
| Dufourmentel, C | 1 |
| Schwartz, SH | 1 |
| Bardos, TJ | 1 |
| Laugier, P | 1 |
| Hunziker, N | 1 |
| Uthida-Tanaka, AM | 1 |
| Nakamura, S | 1 |
| de Britto-Costa, R | 1 |
| de Tavares Mello, E | 1 |
| Nadel, RS | 1 |
| Nitze, HR | 1 |
| Ganzer, U | 1 |
| Glintzer, W | 1 |
| Williams, AC | 1 |
| Landes, E | 1 |
| Spencer, SK | 1 |
| Kierland, RR | 1 |
| Bergonzini, R | 1 |
| Vaccari, R | 1 |
| Zagnoli, P | 1 |
| Scarpa, C | 1 |
| Garcia-Perez, A | 1 |
| Aparicio, M | 1 |
| Carapeto, FJ | 1 |
| Klostermann, GF | 2 |
| Achten, G | 1 |
| Van Oost, A | 2 |
| Ledoux-Corbusier, M | 2 |
| De Moragas, JM | 1 |
| Gimenez-Camarasa, JM | 1 |
| Midana, A | 1 |
| Leigheb, G | 1 |
| Llombart Bosch, M | 1 |
| Espinosa Cabañero, JA | 1 |
| Binazzi, M | 1 |
| Almeida Gonçalves, JC | 1 |
| De Noronha, T | 1 |
| Bettley, FR | 1 |
| Weitgasser, H | 1 |
| Kastl, WH | 1 |
| Knoepp, LF | 1 |
| Soosaar, A | 1 |
| Anderson, FE | 1 |
| Johnson, AM | 1 |
| Havyatt, MT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial[NCT00847912] | Phase 4 | 954 participants (Actual) | Interventional | 2009-06-26 | Completed | ||
| Calcipotriol Plus 5-Fluorouracil Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients[NCT04642287] | Phase 2 | 64 participants (Anticipated) | Interventional | 2026-01-31 | Not yet recruiting | ||
| Calcipotriol Plus 5-Flourouracil Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients[NCT04329221] | Phase 2 | 62 participants (Anticipated) | Interventional | 2026-01-01 | Not yet recruiting | ||
| Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease: a Multicenter Randomized Controlled Trial[NCT03909646] | Phase 4 | 250 participants (Anticipated) | Interventional | 2019-05-27 | Recruiting | ||
| Phase I, Dual Arm, Open-Label, Trial of Intralesional 5-Fluorouracil (5FU) and Intralesional 5FU Combined With Topical Imiquimod in Patients With Squamous Cell Carcinoma (SCC) of the Lower Extremities[NCT03370406] | Phase 1 | 30 participants (Anticipated) | Interventional | 2018-08-03 | Recruiting | ||
| Research on Current Prototypes of the Digiclamp. Short Term and Long Term Outcomes of Treating Adults With Achrocordons (Skin Tags)[NCT03259295] | 20 participants (Actual) | Interventional | 2017-12-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00847912)
Timeframe: date of randomization to last visit before end of study follow up (6/30/2013), assessed up to four years
| Intervention | participants (Number) |
|---|---|
| Arm 1: 5-fluorouracil | 182 |
| Arm 2: Placebo, Vehicle Control | 177 |
Diagnosis of the first Primary Basil Cell Carcinoma (BCC) or primary Squamous Cell Carcinoma (SCC) on the face or ears that was removed surgically. (NCT00847912)
Timeframe: From randomization to last visit prior to end of study date (6/30/2013), assessed up to four years
| Intervention | years (Median) |
|---|---|
| Arm 1: 5-fluorouracil | 3.37 |
| Arm 2: Placebo, Vehicle Control | 3.52 |
Percentage of subjects who develop discoloration at the site of removal (NCT03259295)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 3 |
Percentage of subjects who develop pain/numbness at the site of removal (NCT03259295)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
Percentage of subjects who develop a scar at the removal site (NCT03259295)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 1 |
Percentage of subjects who develop scar tissue or keloid at the site of removal (NCT03259295)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
Percentage of subjects who experience a re-occurrence of the skin tag at the removal site. (NCT03259295)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
39 reviews available for fluorouracil and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Advances in Topical Treatments of Cutaneous Malignancies.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiqui | 2023 |
Nonsurgical Treatments for Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Bi | 2019 |
Topical treatments for skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; D | 2020 |
Field cancerization: Treatment.
Topics: Administration, Cutaneous; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Carcinogenesi | 2020 |
Actinic Keratoses: Reconciling the Biology of Field Cancerization with Treatment Paradigms.
Topics: Administration, Cutaneous; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neo | 2021 |
Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Topics: Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; | 2021 |
Nonsurgical Therapies for Basal Cell Carcinoma: A Review.
Topics: Administration, Cutaneous; Aminoquinolines; Anilides; Antineoplastic Agents; Biphenyl Compounds; Car | 2017 |
Topics: Alopecia; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Basal Cel | 2018 |
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carci | 2019 |
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; | 2013 |
Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis.
Topics: Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fl | 2015 |
Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neop | 2015 |
Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
Topics: Administration, Oral; Anilides; Antineoplastic Agents; Biphenyl Compounds; Capecitabine; Carcinoma, | 2016 |
Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know.
Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; | 2016 |
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
Topics: Administration, Cutaneous; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic | 2009 |
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, S | 2009 |
Intralesional agents in the management of cutaneous malignancy: a review.
Topics: Aminolevulinic Acid; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bleomycin; Carci | 2011 |
Treating skin cancer with topical cream.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; | 2010 |
Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamou | 2010 |
Do lasers or topicals really work for nonmelanoma skin cancers?
Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 2011 |
Emerging treatments and signaling pathway inhibitors.
Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Basal Cell Nevus Syndrome; Benzamides; Carcinoma, | 2011 |
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, S | 2012 |
Diagnosis and treatment of Basal cell and squamous cell carcinoma.
Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cry | 2012 |
Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cryosurgery; Electrosurg | 2003 |
Current treatment patterns in non-melanoma skin cancer across Europe.
Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryothe | 2003 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bio | 2003 |
Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Ag | 2004 |
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments.
Topics: Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Cryosurger | 2008 |
Dermatological aspects of aging.
Topics: Adult; Aged; Aging; Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatitis; Female; Fl | 1983 |
Treatment of skin cancer using multiple modalities.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Electrosurgery; Female; F | 1982 |
Advances in the treatment of basal cell carcinoma: the promise of pharmacologic therapy.
Topics: Adjuvants, Immunologic; Carcinoma, Basal Cell; Fluorouracil; Humans; Interferons; Photochemotherapy; | 2000 |
Nonmelanoma skin cancer.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diet Therapy; Fluorouracil; Humans; Life Style; Neo | 2002 |
A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Anal Canal; Anus Neoplasms; Carc | 1985 |
The use of cytotoxic drugs in the surgery of malignant disease.
Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma, | 1968 |
[Use of optical quantum generators (lasers) in oncology].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Basal Cell; Carcinom | 1972 |
The action of antimetabolites in the skin: methotrexate for psoriasis.
Topics: Carcinoma, Basal Cell; Cell Division; DNA; Fluorouracil; Humans; Injections, Intradermal; Keratosis; | 1972 |
Local cytostatic chemotherapy and immunotherapy.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Drug Hypersensitivity; Fluorouracil; Humans; Neoplasms | 1968 |
Topical treatment of skin tumours with 5-fluorouracil.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratosis; Skin Neoplasms | 1970 |
Topical antimetabolites.
Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Folic Acid Antagonists; | 1970 |
24 trials available for fluorouracil and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Rate and Proportion of Malignant Skin Biopsies for Basal Cell and Squamous Cell Carcinoma on the Face and Ears After a Single Course of Topical 5-Fluorouracil: The Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Basal Cell; Carci | 2021 |
Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment.
Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Choice Behavior; Dermatologic Agents; Drug Therapy, Comb | 2018 |
Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamou | 2018 |
Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Basa | 2018 |
Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Basal Cell; Dermatologic Surgical Procedures; Esthetics; Female; Fluorouraci | 2018 |
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Topics: Adaptive Immunity; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitri | 2019 |
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Topics: Adaptive Immunity; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitri | 2019 |
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Topics: Adaptive Immunity; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitri | 2019 |
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Topics: Adaptive Immunity; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitri | 2019 |
Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
Topics: Administration, Topical; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; D | 2019 |
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antim | 2013 |
Fluorouracil and other predictors of morpheaform basal cell carcinoma among high-risk patients: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Topics: Administration, Topical; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic | 2014 |
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherap | 2014 |
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cel | 2016 |
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Carboplatin; | 2011 |
Facial resurfacing for nonmelanoma skin cancer prophylaxis.
Topics: Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Disease-Fr | 2006 |
Selective cytotoxic effect of topical 5-fluorouracil.
Topics: Administration, Topical; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind | 1983 |
Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Basal Cell; Clin | 1997 |
A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier.
Topics: Administration, Topical; Carcinoma, Basal Cell; Double-Blind Method; Drug Carriers; Fluorouracil; Hu | 2000 |
The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Basal Cell; Double-Blind Method; Drug Carriers; Drug Implants; Female; Fluor | 1992 |
A phase I study of prolonged infusion 5-fluorouracil and concomitant radiation therapy in patients with squamous cell cancer of the head and neck.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Admini | 1991 |
A clinical trial of the use of 5-fluouracil in the treatment of some cutaneous malignancies.
Topics: Adult; Aged; Carcinoma, Basal Cell; Clinical Trials as Topic; Facial Neoplasms; Female; Fluorouracil | 1973 |
The use of topical 5-fluorouracil in the treatment of skin tumours--preliminary report.
Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Clinical Trials as Topic; Female; Fluorouracil; Humans; Kera | 1969 |
Treatment of basal cell carcinoma with 5-fluorouracil (5-FU) ointment.
Topics: Aged; Carcinoma, Basal Cell; Clinical Trials as Topic; Female; Fluorouracil; Humans; Male; Middle Ag | 1970 |
Treatment of skin epitheliomas with 5-fluorouracil (5-FU) ointment. Influence of therapeutic design on recurrence of lesions.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Clinical Trials as T | 1970 |
[Therapeutic trial with 5-fluorouracil ointment].
Topics: Adult; Aged; Carcinoma, Basal Cell; Clinical Trials as Topic; Evaluation Studies as Topic; Facial Ne | 1970 |
Tumors of the skin. V. Local administration of anti-tumor agents to multiple superficial basal cell carcinomas.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Fluorouracil; Humans; Neopla | 1965 |
187 other studies available for fluorouracil and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis.
Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorou | 2022 |
Efficacy and safety of laser-assisted combination chemotherapy: A follow-up study of treatment with 5-fluorouracil and cisplatin for basal cell carcinoma.
Topics: Carcinoma, Basal Cell; Cisplatin; Fluorouracil; Follow-Up Studies; Humans; Lasers; Photochemotherapy | 2022 |
In vitro 5-Fluorouracil resistance produces enhanced photodynamic therapy damage in SCC and tumor resistance in BCC.
Topics: Aminolevulinic Acid; Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; | 2022 |
RF - Intralesional 5-Fluorouracil in the Treatment of Nonmelanoma Skin Cancer.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Injections, Intralesional; Keratoacanthoma; Skin Neopla | 2023 |
Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5-fluorouracil and salicylic acid.
Topics: Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Fluorouracil; Humans; Salicylic Acid; Skin Neoplas | 2022 |
[Current Management of Basal Cell Carcinoma].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod | 2023 |
Cryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma.
Topics: Bowen's Disease; Carcinoma, Basal Cell; Cryosurgery; Fluorouracil; Humans; Retrospective Studies; Sk | 2023 |
Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery.
Topics: Administration, Cutaneous; Aged; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Female; Fluorouracil | 2020 |
Efficacy and Safety of Laser-Assisted Combination Chemotherapy: An Explorative Imaging-Guided Treatment With 5-Fluorouracil and Cisplatin for Basal Cell Carcinoma.
Topics: Carcinoma, Basal Cell; Cisplatin; Fluorouracil; Humans; Lasers, Gas; Proof of Concept Study; Skin Ne | 2021 |
Optimizing the effective doses of mitomycin C, 5-fluorouracil, and their combination on cultivated basal cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Female; Fluorouracil; H | 2021 |
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; | 2021 |
Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid | 2022 |
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer.
Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cetuxi | 2017 |
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cel | 2018 |
Comparing Topical Treatments for Basal Cell Carcinoma.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neopla | 2018 |
Cells to Surgery Quiz: July 2018.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Diseas | 2018 |
Characterization of stem-like cancer cells in basal cell carcinoma and its surgical margins.
Topics: 5'-Nucleotidase; Antineoplastic Agents; Biomarkers; Carcinoma, Basal Cell; Cell Survival; Cisplatin; | 2018 |
Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
Topics: Administration, Cutaneous; Aged; California; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Compar | 2019 |
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
Topics: Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal | 2019 |
Effects of new keratinocyte carcinomas on skin-related quality of life: Results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; C | 2019 |
Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution.
Topics: Adult; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Salicylic Acid; Skin | 2019 |
Topical chemotherapy for numerous superficial basal cell carcinomas years after isolated limb perfusion for melanoma.
Topics: Administration, Cutaneous; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents | 2019 |
Treating basal-cell carcinoma in a real life setting.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod | 2013 |
Effect of pigmentation on photodynamic therapy.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho | 2013 |
Effect of pigmentation on photodynamic therapy - Authors' reply.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho | 2013 |
Treatment of cancer in a child with ocular xeroderma pigmentosa (XP) in Malawi.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; | 2014 |
Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
Topics: Acitretin; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Sq | 2014 |
Resident rounds part III: plaque on left areola of an African-American woman.
Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Biopsy; Black or African American; B | 2014 |
Usage and patient experience of 5% fluorouracil cream.
Topics: Antimetabolites, Antineoplastic; Bowen's Disease; Carcinoma, Basal Cell; Cost Control; Fluorouracil; | 2015 |
Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Ag | 2015 |
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho | 2015 |
Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho | 2015 |
Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho | 2015 |
Tumors of the skin. VI. Study on effects of local administration of 5-fluorouracil in basal cell carcinoma.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Fol | 1966 |
Fast-growing cutaneous squamous cell carcinoma in a patient treated with vismodegib.
Topics: Aged, 80 and over; Anilides; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basa | 2015 |
Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, | 2015 |
Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil | 2015 |
Integrative approach in prevention and therapy of basal cellular carcinoma by association of three actives loaded into lipid nanocarriers.
Topics: Amaranthus; Antioxidants; Calorimetry, Differential Scanning; Carcinoma, Basal Cell; Drug Carriers; | 2015 |
Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcino | 2015 |
Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marr | 2016 |
Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinom | 2016 |
Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Face; Fluorouracil; | 2016 |
Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Carcinoma, Squamous | 2010 |
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Basement Membrane; Blister; Carcinoma, Basal Cell; Cry | 2010 |
[Surgical vs nonsurgical treatment of basal cell carcinoma].
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Combined Mo | 2010 |
[Four resected cases with basaloid carcinoma of esophagus--comparison of 5-FU-related enzymes (thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT)) between basaloid carcinoma and squamous cell carcin
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dihydrouraci | 2010 |
Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antimetabolites; Carcinoma, Basal Cel | 2010 |
Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma.
Topics: Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Esthetics; Female; Fluorouracil; Humans; Imiqui | 2013 |
Multiple basal cell carcinomas of lower legs with stasis dermatitis: a therapeutic challenge.
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Hamartoma S | 2012 |
Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.
Topics: Administration, Oral; Adolescent; Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, B | 2013 |
Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Basal Cell; Floxuridine; Fluorouracil; Humans; Male; Mesopor | 2003 |
INFUSION OF 5-FLUOROURACIL IN CYLINDROMA TREATMENT.
Topics: Carcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Basal Cell; Fluorouracil; Humans; Injections, Intra | 1964 |
TUMORS OF THE SKIN. IV. DOUBLE-BLIND STUDY ON EFFECTS OF LOCAL ADMINISTRATION OF ANTI-TUMOR AGENTS IN BASAL CELL CARCINOMA.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Dactinomycin; Double-Blind Method; Drug Therapy; Fluor | 1965 |
Basaloid squamous carcinoma of the anal canal with an adenoid cystic pattern: histologic and immunohistochemical reappraisal of an unusual variant.
Topics: Anal Canal; Antibiotics, Antineoplastic; Antigens, CD20; Antimetabolites, Antineoplastic; Antineopla | 2005 |
[The outcome of treatments for carcinoma of the external auditory canal].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2005 |
Basal cell carcinoma responding to systemic 5-fluorouracil.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Male; Middle Aged; Ski | 2006 |
How can we decide on orbital exenteration for second eye in a patient with basal cell carcinoma?
Topics: Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Cheek; Dose Fractionation, Radiation; Fluorourac | 2006 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormon | 2006 |
Basal cell carcinoma.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Causality; Cryosurgery; | 2006 |
5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction.
Topics: Administration, Topical; Adult; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil | 2007 |
Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Anus N | 2008 |
[Experience on topical 5-fluoruracil- (5-FU) in cutaneous carcinomatosis. I. Test on the efficiency of topical 5-FU].
Topics: Carcinoma, Basal Cell; Cheilitis; Facial Dermatoses; Female; Fluorouracil; Hand Dermatoses; Humans; | 1966 |
Chemical treatment of skin cancer.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Colchicine; Fluorouracil; Humans; Methotrexate; Pod | 1967 |
Combination chemotherapy for the treatment of metastatic basal cell carcinoma of the scrotum. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Cisplatin; Fluorou | 1984 |
Management of common skin tumours.
Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Dermatitis, Seborrhei | 1980 |
Carcinoma of the hand: a 20-year experience.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Female; Fluorouracil; Fol | 1984 |
Basal cell carcinoma. Treatment modalities and recommendations.
Topics: Carcinoma, Basal Cell; Cryosurgery; Electrosurgery; Facial Neoplasms; Fluorouracil; Humans; Neoplasm | 1983 |
[Maxillofacial surgical treatment of basaliomas in the basocellular nevus syndrome].
Topics: Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Facial Neoplasms; Female; Fluorouracil; Humans; Ma | 1983 |
[Procedure and results of combined radiation and surgical treatment of laryngeal cancer patients].
Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality T | 1983 |
Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene.
Topics: Administration, Topical; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Child; Dinitrochlorobenze | 1984 |
Porokeratosis associated with basal cell carcinoma.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Skin Neoplasms | 1982 |
Nodular superficial pigmented basal cell epitheliomas.
Topics: Administration, Topical; Carcinoma, Basal Cell; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, | 1982 |
Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
Topics: Adult; Carcinoma, Basal Cell; Fluorouracil; Humans; Injections, Intradermal; Keratoacanthoma; Male; | 1980 |
"Ecdysis" secondary to 5-fluorouracil.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Middle Aged; Skin; Skin Neoplasms; Steven | 1980 |
Facial blemishes and their treatment.
Topics: Carcinoma, Basal Cell; Chemexfoliation; Cryosurgery; Curettage; Electrosurgery; Facial Dermatoses; F | 1980 |
[Efudix therapy of extensive basal cell carcinomas].
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Ointments; Skin Neopla | 1980 |
Basal cell carcinoma.
Topics: Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Cryosurgery; Female; Fluorouracil; Humans; Male; N | 1980 |
Myocardial ischemia induced by topical use of 5-fluorouracil.
Topics: Administration, Topical; Aged; Aged, 80 and over; Angina Pectoris; Carcinoma, Basal Cell; Drug Thera | 1995 |
[Cisplatin-based chemotherapy for advanced basal and squamous cell carcinomas].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carc | 1994 |
Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome.
Topics: Administration, Topical; Back; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Combined Modality T | 1993 |
High frequency 40-MHz ultrasound. A possible noninvasive method for the assessment of the boundary of basal cell carcinomas.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Basal Cell; Female; Flu | 1996 |
Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.
Topics: Aged; Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Basal Cell; Diarrhea; Dihydrour | 1999 |
Guidelines for the management of basal cell carcinoma. British Association of Dermatologists.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Interferon Type I; Pal | 1999 |
[Topical chemotherapy for carcinoma of the skin (author's transl)].
Topics: Administration, Topical; Adolescent; Aged; Bleomycin; Bowen's Disease; Carcinoma, Basal Cell; Carcin | 1975 |
Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study.
Topics: Administration, Topical; Carcinoma, Basal Cell; Curettage; Fluorouracil; Follow-Up Studies; Humans; | 1979 |
Basal-cell tumors of the lumbar skin after radiotherapy for arthrosis.
Topics: Administration, Topical; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Joint Diseases; | 1979 |
Squamous-cell carcinoma arising in a basal-cell epithelioma treated with 5-fluorouracil.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Male; Neoplasms, Multi | 1979 |
Extensive malignancies of facial skin treated by perfusion with 5-fluorouracil and conservative excision.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Fluorouracil; Human | 1979 |
Basal cell nevus syndrome and adenocarcinoma of the colon. Response to systemic fluorouracil.
Topics: Adenocarcinoma; Adult; Carcinoma, Basal Cell; Colonic Neoplasms; Female; Fluorouracil; Humans; Nevus | 1979 |
Hypertrophic scarring as a complication of fluorouracil therapy.
Topics: Adult; Carcinoma, Basal Cell; Cicatrix; Fluocinonide; Fluorouracil; Humans; Hypertrophy; Male; Skin | 1979 |
[Involution of tumor tissue during local treatment of basal cell epithelioma with 5-fluorouracil].
Topics: Adult; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged | 1977 |
A short survey on the use and efficacy of 5-fluorouracil in Australia.
Topics: Aged; Australia; Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Skin Diseases; Skin Neoplas | 1978 |
5-fluorouracil in management of Gorlin's syndrome.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Skin Neoplasms; Syndrome | 1978 |
5-fluorouracil in Gorlin's syndrome.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Jaw Diseases; Skin Neoplasms; Syndrome | 1978 |
[Vitamin A acid for the topical management of epithelial neoplasms. Combination with 5-fluorouracil].
Topics: Aged; Carcinoma, Basal Cell; Drug Therapy, Combination; Female; Fluorouracil; Humans; Keratosis; Leu | 1978 |
Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma.
Topics: Administration, Topical; Carcinoma, Basal Cell; Face; Fluorouracil; Humans; Neoplasm Recurrence, Loc | 1978 |
[Topical use of antineoplastic agents in precancerous conditions of the skin].
Topics: Administration, Topical; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Kera | 1977 |
Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapy.
Topics: Administration, Topical; Carcinoma, Basal Cell; Diarrhea; Fluorouracil; Humans; Injections, Intraven | 1976 |
Topical 5-fluorouracil and the basal-cell-nevus syndrome.
Topics: Administration, Topical; Carcinoma, Basal Cell; Fluorouracil; Humans; Nevus | 1976 |
Letter: Basal cell carcinoma.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Methods | 1975 |
Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
Topics: Administration, Topical; Biopsy; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquamous; | 1975 |
The "turban" nevoid basal cell syndrome. Current management with surgery, chemotherapy and immunotherapy.
Topics: Adult; Bone Cysts; Carcinoma, Basal Cell; Dinitrochlorobenzene; Fluorouracil; Humans; Jaw Diseases; | 1975 |
Topical 5-fluorouracil treatment of superficial basal cell epithelioma. A light and electron microscopic study.
Topics: Administration, Topical; Adult; Carcinoma, Basal Cell; Cell Nucleus; Cytoplasm; Endoplasmic Reticulu | 1975 |
Intradermal 5-fluorouracil in the treatment of basal cell carcinoma of the face.
Topics: Aged; Carcinoma, Basal Cell; Facial Neoplasms; Female; Fluorouracil; Humans; Injections, Intradermal | 1976 |
Current thoughts on the surgical treatment of rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; | 1976 |
Metastatic basal cell carcinoma: report of a case presenting with respiratory failure.
Topics: Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neopla | 1991 |
[The importance of local administration of 5% 5-fluorouracil in the therapy of senile keratoses and basocellular carcinoma].
Topics: Administration, Topical; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Male; | 1989 |
Preoperative radio-chemotherapy in anal carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Basal Cell; Carcino | 1988 |
Topical 5-fluorouracil in treatment of carcinoma of nasal floor and nasal alae.
Topics: Administration, Topical; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Th | 1988 |
[Multiple basalomas following long-term intake of arsenic].
Topics: Administration, Oral; Administration, Topical; Anemia; Arsenic; Arsenites; Carcinoma, Basal Cell; Fe | 1985 |
Fluorouracil paste treatment of thin basal cell carcinomas.
Topics: Adult; Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Lo | 1985 |
[Neoplasms of the vulva].
Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Erythroplasi | 1985 |
Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck.
Topics: Age Factors; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell | 1972 |
[Multicentric metatypical scalp basalioma (ulcus terebans) with perforation into the cranium].
Topics: Aged; Autopsy; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Palliative Care; Scalp; Skin Neo | 1974 |
[Comparative topic treatments of basal cell carcinomas and senile keratoses with 5-FU, retinoic acid and DNCB sensitization (author's transl)].
Topics: Administration, Topical; Carcinoma, Basal Cell; Chlorobenzenes; Fluorouracil; Humans; Immunotherapy; | 1974 |
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy.
Topics: Aged; Antineoplastic Agents; Biopsy, Needle; Bleomycin; Carcinoma, Basal Cell; Cyclophosphamide; Dru | 1974 |
Treatment of skin cancers and keratoses with 5-fluorouracil.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Male; Ointments; Skin Neoplasms | 1968 |
[Therapeutic possibilities in multiple epitheliomas of the trunk skin].
Topics: Arsenic; Carcinoma, Basal Cell; Electrocoagulation; Female; Fluorouracil; Humans; Long-Term Care; Ma | 1973 |
Actinic keratoses in Bantu albinos. Clinical experiences with the topical use of 5-fluoro-uracil.
Topics: Adult; Albinism; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Catechol Oxidase; Child; Female; F | 1973 |
Untoward response with topical fluorouracil.
Topics: Aged; Carcinoma, Basal Cell; Drug Eruptions; Female; Fluorouracil; Humans; Keratosis; Male; Middle A | 1968 |
Minor surgery for benign and malignant facial lesions.
Topics: Acne Vulgaris; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cicatrix; Cortisone; Curettage; Cyst | 1974 |
[Effect of 5-fluorouracil on protein metabolism of tumors and normal tissues in culture].
Topics: Adenocarcinoma; Animals; Autoradiography; Carcinoma, Basal Cell; Cell Line; Cell Transformation, Neo | 1970 |
[Local treatment of skin neoplasms with 5 per cent fluorouracil ointment (report of 6 cases)].
Topics: Adenocarcinoma, Scirrhous; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorourac | 1972 |
Tumors of the skin. Premalignment and malignant.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorouracil; Humans; Kera | 1974 |
Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinom | 1974 |
Combined cytostatic and surgical treatment of extensive basal cell epitheliomata.
Topics: Aged; Carcinoma, Basal Cell; Facial Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Skin Transpl | 1972 |
[Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middl | 1972 |
Local chemotherapy in cutaneous neoplasms.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Skin Neoplasms | 1972 |
Multiple basal cell epitheliomas with sebaceous differentiation.
Topics: Carcinoma, Basal Cell; Cell Differentiation; Child; Curettage; Diagnosis, Differential; Electrosurge | 1973 |
The clinical application of 5-fluorouracil in the treatment of skin lesions. Comment.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Skin Neoplasms | 1973 |
Topical use of 5-fluorouracil.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local; Skin Neoplasm | 1973 |
Multiple basal cell naevus syndrome--successful treatment of basal cell tumours with 5-fluorouracil.
Topics: Adult; Carcinoma, Basal Cell; Dentigerous Cyst; Fluorouracil; Humans; Jaw Diseases; Male; Skin Neopl | 1973 |
Hypertrophic scar after cryotherapy and topical tretinoin.
Topics: Administration, Topical; Carcinoma, Basal Cell; Carmustine; Cicatrix; Connective Tissue; Cryosurgery | 1973 |
Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquam | 1972 |
Proceedings: Chemotherapy and immunotherapy for cancer involving the skin.
Topics: Administration, Topical; Antigens, Bacterial; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinom | 1972 |
Additional observations on the nevoid basal cell epithelioma syndrome. A case report.
Topics: Adolescent; Carcinoma, Basal Cell; Cysts; Fluorouracil; Humans; Jaw Abnormalities; Jaw Diseases; Jaw | 1973 |
Effect of topical tubercidin on basal cell carcinomas and actinic keratoses.
Topics: Adenosine; Administration, Topical; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Kerat | 1974 |
The clinical application of 5-fluorouracil in the treatment of skin lesions.
Topics: Adolescent; Adult; Carcinoma, Basal Cell; Child; Child, Preschool; Dermatologic Agents; Fluorouracil | 1968 |
The use of 5-fluorouracil cream to define suitable donor areas.
Topics: Adult; Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Male; Middle Aged; Ointments; Skin Neoplas | 1970 |
Xeroderma pigmentosum--five-year arrest after total resurfacing of the face.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Dermabrasion; Electrosurgery; Fac | 1970 |
[5-Fluorouracil and Bucky rays in the treatment of superficial basaliomas].
Topics: Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Methods; Middle Aged; Ointments; Skin Neoplasms | 1972 |
Topical chemotherapy of cutaneous neoplasms.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Leukop | 1972 |
[Therapeutic effects of 5-florouracil ointment on various skin diseases].
Topics: Adolescent; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Huma | 1972 |
A follow-up study of treatment of basal cell carcinoma with 5-fluorouracil ointment.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Follow-Up Studies; Humans; Neoplasm Recu | 1972 |
Treatment of basal and squamous cancers of the nose and ear with 5-fluorouracil cream.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Ear Neoplasms; Female; Fluorouracil; Follow-U | 1971 |
Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chlorine; Facial Neoplasms; | 1971 |
Tumors of the skin. XII. Topical 5-Fluorouracil for epidermal neoplasms.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatitis; Esthetics; Female; Fluorouracil; Humans | 1971 |
Topical chemotherapy of advanced cutaneous malignancy with 5-Fluorouracil creme.
Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Esthetics | 1971 |
Topical use of 5-fluorouracil cream for skin cancer.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Ointments; Skin Neopla | 1971 |
[Topical therapy of superficial basalioma and senile keratoma with 5-fluorouracil].
Topics: Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Precancerous Conditions; Skin Neoplasm | 1971 |
[Trials using local 5-FU therapy in precancerous states and cancer of the skin].
Topics: Carcinoma, Basal Cell; Fluorouracil; Follow-Up Studies; Humans; Keratosis; Ointments; Precancerous C | 1971 |
[5-Fluorouracil in local therapy of precancerous conditions and carcinoma of the skin].
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratosis; Neoplasm Recurrenc | 1971 |
[Treatment of cutaneous tumors with fluorouracil ointment].
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Keratosi | 1971 |
Topical 5-fluorouracil: variability of effective dosage and duration of reaction.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Skin Neoplasms | 1971 |
[Value of the use of a 5-fluorouracil ointment in the treatment of basal cell epitheliomas in the aged].
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Ointments; Skin Neoplasms | 1971 |
Xeroderma pigmentosum.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Eyelid Neoplasms; Female; | 1971 |
[Apropos of 40 cases of malignant tumors treated by local-regional and general chemotherapy in a surgical department].
Topics: Adolescent; Adult; Aminopterin; Back; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemotherapy, | 1969 |
Cytostatic and immunologic activity of 5-mercaptouracil desoxyriboside in the management of multiple superficial basal cell epitheliomas.
Topics: Antimetabolites; Carcinoma, Basal Cell; Deoxyuridine; DNA, Neoplasm; Fluorouracil; Humans; Hypersens | 1970 |
[Treatment of skin cancer].
Topics: Age Factors; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Lip Neoplasms; Male; Melanoma; Pro | 1971 |
[Topical therapy of precancerous lesions and skin carcinomas using a 5-fluorouracil ointment].
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Fluorouracil | 1969 |
[Synchronization of histologically normal human tissue].
Topics: Antineoplastic Agents; Autoradiography; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; DNA; DNA, N | 1969 |
Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions.
Topics: Antigen-Antibody Reactions; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatitis; Dermatitis, | 1970 |
[Treatment of carcinoma and precancerosis using 5-fluorouracil].
Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Occlusive Dressings | 1970 |
The aging skin: problems and their causes.
Topics: Aged; Aging; Arsenicals; Balanitis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorou | 1970 |
[On the treatment of superficial neoplasms with 5-FU ointment. Preliminary review].
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Ointments; Skin Neoplasms | 1970 |
Summary of our trial with 5-fluorouracil (5-FU) ointment on the treatment of basal cell epithelioma and senile keratosis.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Ointments; Skin Neoplasms; Time Factors | 1970 |
Comparison of the clinical and histological effects of 5-fluorouracil (5-FU) alone and of 5-FU preceded by dimethyl-sulphoxide (DMSO) on senile keratosis.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dimethyl Sulfoxide; Fluorouracil; Humans; Keratosis | 1970 |
Effects of 5-fluorouracil (5-FU) ointment on normal and diseased skin. Histological findings and deep action.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Ointments; Skin Neoplasms | 1970 |
Basal-cell carcinoma of large dimension.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Skin Neoplasms | 1970 |
5-fluorouracil (5-FU) ointment in the treatment of basal cell epithelioma. Histological control over a long duration.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Male; Middle Ag | 1970 |
5-fluorouracil ointment in tumors of the skin.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratoacanthoma; Keratosis; Male; Middle | 1970 |
5-fluorouracil (5-FU) ointment in the treatment of benign and malignant skin lesions.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; L | 1970 |
Preliminary experience with 5-fluorouracil ointment in the treatment of neoplasias and precancerous lesions of the skin.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Neoplasm Metast | 1970 |
Clinical and structural evaluation of the treatment of some hyperplastic and neoplastic skin diseases with 5-fluorouracil (5-FU) ointment.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Ointments; Skin Neoplasms; Ti | 1970 |
5-fluouracil (5-FU) ointment in the treatment of skin tumours and keratoses.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Keratoacanthoma | 1970 |
[Cytostatics in basalioma therapy?].
Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Ointments | 1970 |
[Electron microscopy studies on the effect of 5-fluorouracil on basaliomas].
Topics: Back; Biopsy; Carcinoma, Basal Cell; Facial Neoplasms; Fluorouracil; Humans; Microscopy, Electron; S | 1971 |
The treatment of skin carcinoma with podophyllum derivatives.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Colchicine; Fluorouracil; Hu | 1971 |
[Therapy of basal cell carcinoma of the skin with fluorouracil salve].
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Occlusive Dressings; O | 1968 |
[Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment].
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Keratoacanthoma | 1968 |
[Local chemotherapy in the treatment of basal cell epithelioma. 1st results obtained by topical application of 5 fluoro-uracil].
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Occlusive Dressings; Ointments; Skin Neoplasms | 1968 |
[Experiences with a cytostaticly active ointment in the dermatologic practice. (5 per cent--5-fluorouracil ointment)].
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Lichen P | 1969 |
Tumors of the skin. XI. Effect of occlusive dressing on the local administration of 5-fluorouracil to superficial basal cell carcinoma.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Occlusive Dressings; O | 1969 |
Topical chemotherapy of cutaneous malignancy of the head and neck.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Head and Neck Neoplasms; Humans; Kera | 1969 |
The topical application of 5-fluorouracil in the treatment of skin lesions.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Male; Skin Neoplasms | 1969 |
Fluorouracil topically for skin cancer.
Topics: Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Male; Ointments; Propylene Glycols; Sk | 1969 |
Preliminary studies in the use of 5-fluoro-uracil cream in the treatment of malignant and premalignant skin tumours.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; O | 1969 |